FDA Inspection 1245719 — Apitoria Pharma Private Limited

Apitoria Pharma Private Limited — FEI 3004051616

The FDA completed an inspection of Apitoria Pharma Private Limited on March 3, 2023 in Sangareddy. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 3, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Sangareddy (India)

Additional Details

Mutual Recognition Agreement (MRA)